Evidence map›Paper›PMID 17081700›Full record

Trial reportPsychoneuroendocrinology2006

Stress sensitivity in metastatic breast cancer: analysis of hypothalamic-pituitary-adrenal axis function.

David Spiegel, Janine Giese-Davis, C Barr Taylor, Helena Kraemer

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Psychoneuroendocrinology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2011
    Trial
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Salivary Alpha-Amylase Reactivity in Breast Cancer Survivors.International journal of environmental research and public health · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

David SpiegelDepartment of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305-5718, USA. dspiegel@stanford.edu
Janine Giese-Davis
C Barr Taylor
Helena Kraemer
Stanford University · US

Funding

XOLAIR IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS WITH FOOD ALLERGYM01RR000070 · NCRR · STANFORD UNIVERSITY · PI RASGON, NATALIE L · 1985 to 2008
$32.4M
Stress, The HPA and Health in AgingP01AG018784 · NIA · STANFORD UNIVERSITY · PI SPIEGEL, DAVID · 2001 to 2008
$8.7M
SMALL INSTRUMENTATION PROGRAMS15AG008784 · NIA · CALIFORNIA STATE UNIVERSITY LONG BEACH · PI JENSEN, JAMES L · 1989 to 1989
–
NCRR NIH HHS 5M01 RR 000070NCRR NIH HHS M01 RR000070NCRR NIH HHS M01 RR000070-420502NCRR NIH HHS M01 RR000070-430502NIA NIH HHS AG A8784NIA NIH HHS P01 AG018784NIA NIH HHS P01 AG018784-01A1NIA NIH HHS P01 AG018784-02NIA NIH HHS P01 AG018784-020001NIA NIH HHS P01 AG018784-02S1NIA NIH HHS P01 AG018784-03NIA NIH HHS P01 AG018784-04NIA NIH HHS P01 AG018784-04S1NIA NIH HHS P01 AG018784-04S2NIA NIH HHS P01 AG018784-05
6 · The paper itself

Abstract

The normal diurnal cortisol cycle has a peak in the morning, decreasing rapidly over the day, with low levels during the night, then rising rapidly again to the morning peak. A pattern of flatter daytime slopes has been associated with more rapid cancer progression in both animals and humans. We studied the relationship between the daytime slopes and other daytime cortisol responses to both pharmacological and psychosocial challenges of hypothalamic-pituitary-adrenal (HPA) axis function as well as DHEA in a sample of 99 women with metastatic breast cancer, in hopes of elucidating the dysregulatory process. We found that the different components of HPA regulation: the daytime cortisol slope, the rise in cortisol from waking to 30 min later, and cortisol response to various challenges, including dexamethasone (DEX) suppression, corticotrophin releasing factor (CRF) activation, and the Trier Social Stress Task, were at best modestly associated. Escape from suppression stimulated by 1mg of DEX administered the night before was moderately but significantly associated with flatter daytime cortisol slopes (r=0.28 to .30 at different times of the post DEX administration day, all p<.01). Daytime cortisol slopes were also moderately but significant associated with the rise in cortisol from waking to 30 min after awakening (r=.29, p=.004, N=96), but not with waking cortisol level (r=-0.13, p=.19). However, we could not detect any association between daytime cortisol slope and activation of cortisol secretion by either CRF infusion or the Trier Social Stress Task. The CRF activation test (following 1.5mg of DEX to assure that the effect was due to exogenous CRF) produced ACTH levels that were correlated (r=0.66, p<.0001, N=74) with serum cortisol levels, indicating adrenal responsiveness to ACTH stimulation. Daytime cortisol slopes were significantly correlated with the slope of DHEA (r=.21, p=.04, N=95). Our general findings suggest that flatter daytime cortisol slopes among metastatic breast cancer patients may be related to disrupted feedback inhibition rather than hypersensitivity in response to stimulation.

Indexed as

Adrenocorticotropic HormoneAdultArousalBreast NeoplasmsCircadian RhythmDehydroepiandrosteroneDexamethasoneFemaleHumansHydrocortisoneHypothalamo-Hypophyseal SystemMiddle AgedNeoplasm MetastasisPituitary-Adrenal Function TestsPituitary-Adrenal SystemSalivaAdrenocorticotropic HormoneDehydroepiandrosteroneDexamethasoneHydrocortisone

Identifiers

PMID17081700
PMCPMC1790857
OpenAlexW2041687686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.